Literature DB >> 165915

Circulating levels of corticotrophin and cortisol after infusions of L-DOPA, dopamine and noradrenaline, in man.

C S Wilcox, M J Aminoff, J G Millar, J Keenan, M Kremer.   

Abstract

Intravenous infusions of noradrenaline and dopamine in normal saline, and L-dopa in sodium lactate, were given to seven patients with Parkinsonism, and to five healthy volunteers. Infusions of saline and lactate were given, in a similar manner, to six additional healthy volunteers, who formed a control group. Dopamine and noradrenaline were each given in gradually increasing doses, for periods of 4 min, until a 30% increase in systolic blood pressure had occurred. L-Dopa (320 mg) was given a constant rate of infusion over 80 min. Plasma fluorogenic corticosteroids (cortisol) increased with dopamine , and decreased with noradrenaline. These changes were significantly different from the control group in the case of noradrenaline only. ACTH values changed in a similar manner. L-Dopa produced a consistent rise in both ACTH and cortisol that was significantly different from control subjects. The implications of these observations are discussed.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 165915     DOI: 10.1111/j.1365-2265.1975.tb01526.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  8 in total

1.  Reduced morning cortisol secretion in patients with multiple system atrophy.

Authors:  T Ozawa; Y Soma; N Yoshimura; N Fukuhara; M Tanaka; S Tsuji
Journal:  Clin Auton Res       Date:  2001-08       Impact factor: 4.435

2.  The atypical antipsychotics olanzapine and quetiapine, but not haloperidol, reduce ACTH and cortisol secretion in healthy subjects.

Authors:  Stefan Cohrs; Cornelia Röher; Wolfgang Jordan; Andreas Meier; Gerald Huether; Wolfgang Wuttke; Eckart Rüther; Andrea Rodenbeck
Journal:  Psychopharmacology (Berl)       Date:  2006-01-24       Impact factor: 4.530

3.  Monoamines, BDNF, IL-6 and corticosterone in CSF in patients with Parkinson's disease and major depression.

Authors:  Sven Pålhagen; Hongshi Qi; Björn Mårtensson; Jan Wålinder; Ann-Kathrine Granérus; Per Svenningsson
Journal:  J Neurol       Date:  2009-10-21       Impact factor: 4.849

Review 4.  Effects of catecholamines on secretion of adrenocorticotrophic hormone (ACTH) in man.

Authors:  S Al-Damluji; L H Rees
Journal:  J Clin Pathol       Date:  1987-09       Impact factor: 3.411

5.  Human detectability of various modulation wave forms in frequency-modulated tones [proceedings].

Authors:  G G Green; R H Kay; S M Wighton
Journal:  J Physiol       Date:  1978-09       Impact factor: 5.182

6.  Effects of psychotropic drugs (desimipramine, chlorimipramine, sulpiride and diazepam) on the human HPA axis.

Authors:  G Laakmann; M Wittmann; M Gugath; O A Mueller; J Treusch; U Wahlster; G K Stalla
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

7.  The influence of the infusion of noradrenaline on plasma cortisol levels in man.

Authors:  J D Few; M J Gawel; F J Imms; E M Tiptaft
Journal:  J Physiol       Date:  1980-12       Impact factor: 5.182

8.  Activation of the JAK-STAT pathway by olanzapine is necessary for desensitization of serotonin2A receptor-stimulated phospholipase C signaling in rat frontal cortex but not serotonin2A receptor-stimulated hormone release.

Authors:  R K Singh; C Jia; F Garcia; G A Carrasco; G Battaglia; N A Muma
Journal:  J Psychopharmacol       Date:  2009-03-20       Impact factor: 4.153

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.